Revision history of "GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide" (Q42482163)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

24 November 2024

21 November 2024

22 August 2023

  • curprev 22:4322:43, 22 August 2023 KrBot talk contribs 30,180 bytes −1 Set a claim value: title (P1476): GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide undo (restore)
  • curprev 22:4322:43, 22 August 2023 KrBot talk contribs 30,181 bytes −1 Changed Dutch label: GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide undo (restore)
  • curprev 22:4322:43, 22 August 2023 KrBot talk contribs 30,182 bytes −1 Changed English label: GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide undo (restore)

1 February 2022

20 May 2021

3 September 2020

17 July 2020

17 August 2019

4 January 2019

8 November 2018

4 October 2018

24 August 2018

1 November 2017